Pharma M&A round-up 2025: protecting against patent cliffs to come

Pharma M&A spend in 2025 exceeded $150 billion, higher than the sum spent in both 2024 and 2023. Companies are trying to protect themselves against impending patent cliffs, triggering the increase in M&A activity.